Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
1 hedge funds and large institutions have $248K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
11.59% less ownership
Funds ownership: 19.35% → 7.76% (-12%)
50% less funds holding
Funds holding: 2 → 1 (-1)
77% less capital invested
Capital invested by funds: $1.07M → $248K (-$825K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$287K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$264K |
PILL Hedge Fund Activity: Q4 2018 in Review
1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q4 2018, worth a combined $248K — down 77% from $1.07M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PILL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Jane Street, cutting an estimated $287K.
- 1 institutional investor held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q4 2018, down from 2 in Q3 2018.
- Funds reported $248K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q4 2018, down 77% quarter-over-quarter.
- 0 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q4 2018 and 1 closed out, a net change of -1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q4 2018 was Jane Street, an estimated $287K sold.
Based on aggregated 13F filings for Q4 2018.